Lipocalin 2 regulation and its complex role in inflammation and cancer

Cytokine

Volumn 56, Issue 2, 2011, Pages 435-441

  Li, Chen ^a   Chan, Yvonne R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

24p3; Lipocalin 2; NGAL; Regulation; Siderocalin

Indexed keywords

CYTOKINE; IRON; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ARTICLE; BACTERIAL INFECTION; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL SURVIVAL; CYTOKINE RELEASE; ENVIRONMENTAL STRESS; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; INFLAMMATION; IRON TRANSPORT; MALIGNANT NEOPLASTIC DISEASE; METABOLIC STRESS; MUCOSAL IMMUNITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPRODUCTION; SIGNAL TRANSDUCTION; TISSUE REACTION;

ACUTE-PHASE PROTEINS; BASE SEQUENCE; DISEASE PROGRESSION; DNA; HUMANS; INFLAMMATION; LIPOCALINS; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION;

EID: 80053327102     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.07.021     Document Type: Article

References (117)

1. Hraba-Renevey S., Turler H., Kress M., Salomon C., Weil R. SV40-induced expression of mouse gene 24p3 involves a post-transcriptional mechanism. Oncogene 1989, 4:601-608.
2. Flower D.R., North A.C.T., Attwood T.K. Mouse oncogene protein 24p3 is a member of the lipocalin protein family. Biochem Biophys Res Commun 1991, 180:69-74.
3. Kjeldsen L., Johnsen A.H., Sengelov H., Borregaard N. Isolation primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993, 268:10425-10432.
4. Triebel S., Blaser J., Reinke H., Tschesche H. A 25kDa alpha 2-microglobulin-related protein is a component of the 125kDa form of human gelatinase. FEBS Lett 1992, 314:386-388.
5. Kanai M., Raz A., Goodman D.S. Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 1968, 47:2025-2044.
6. Urade Y., Fujimoto N., Hayaishi O. Purification and characterization of rat brain prostaglandin D synthetase. J Biol Chem 1985, 260:12410-12415.
7. Morel L., Dufaure J.P., Depeiges A. LESP, an androgen-regulated lizard epididymal secretory protein family identified as a new member of the lipocalin superfamily. J Biol Chem 1993, 268:10274-10281.
8. Goetz D.H., Holmes M.A., Borregaard N., Bluhm M.E., Raymond K.N., Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002, 1033-1043.
9. Bao G., Clifton M., Hoette T.M., Mori K., Deng S.X., Qiu A., et al. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol 2010, 602-609.
10. Cowland J.B., Borregaard N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 1997, 45:17-23.
11. Chen Z., Chen J., Weng T., Jin N., Liu L. Identification of rat lung - Prominent genes by a parallel DNA microarray hybridization. BMC Genomics 2006, 47.
12. Haase M., Bellomo R., Devarajan P., Schlattmann P., Haase-Fielitz A. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 2009, 1012-1024.
13. Nickolas T.L., Barasch J., Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens 2008, 17:127-132.
14. Rubinstein T., Pitashny M., Putterman C. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/lipocalin-2 as a biomarker for lupus nephritis. Autoimmun Rev 2008, 7:229-234.
15. Wheeler D.S., Devarajan P., Ma Q., Harmon K., Monaco M., Cvijanovich N., et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med 2008, 36:1297-1303.
16. Ling W., Zhaohui N., Ben H., Leyi G., Jianping L., Huili D., et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract 2008, 108:c176-c181.
17. Wagener G., Jan M., Kim M., Mori K., Barasch J.M., Sladen R.N., et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006, 105:485-491.
18. Shapiro N.I., Trzeciak S., Hollander J.E., Birkhahn R., Otero R., Osborn T.M., et al. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 2009, 37:96-104.
19. Yan L., Borregaard N., Kjeldsen L., Moses M.A. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 2001, 37258-37265.
20. Li S.H., Hawthorne V.S., Neal C.L., Sanghera S., Xu J., Yang J., et al. Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation. Cancer Res 2009, 9163-9168.
21. Moniaux N., Chakraborty S., Yalniz M., Gonzalez J., Shostrom V.K., Standop J., et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer 2008, 1540-1547.
22. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 917-921.
23. Wu H., Santoni-Rugiu E., Ralfkiaer E., Porse B.T., Moser C., Hoiby N., et al. Respir Res 2010, 96.
24. Akgul B., Bauer B., Zigrino P., Storey A., Mauch C., Pfister H. Upregulation of lipocalin-2 in HPV-positive keratinocytes and cutaneous squamous cell carcinomas. J Gen Virol 2010.
25. Berger T., Togawa A., Duncan G.S., Elia A.J., You-Ten A., Wakeham A., et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci USA 2006, 103:1834-1839.
26. Fischbach M.A., Lin H., Zhou L., Yu Y., Abergel R.J., Liu D.R., et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA 2006, 16502-16507.
27. Chan Y.R., Liu J.S., Pociask D.A., Zheng M., Mietzner T.A., Berger T., et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J Immunol 2009, 4947-4956.
28. Bachman M.A., Miller V.L., Weiser J.N. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog 2009, 5:e1000622.
29. Nelson A.L., Barasch J.M., Bunte R.M., Weiser J.N. Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity. Cell Microbiol 2005, 1404-1417.
30. Rodriguez N., Mages J., Dietrich H., Wantia N., Wagner H., Lang R., et al. MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae. Physiol Genomics 2007, 134-145.
31. Godinez I., Haneda T., Raffatellu M., George M.D., Paixao T.A., Rolan H.G., et al. T cells help to amplify inflammatory responses induced by Salmonella enterica serotype Typhimurium in the intestinal mucosa. Infect Immun 2008, 76:2008-2017.
32. Nairz M., Theurl I., Ludwiczek S., Theurl M., Mair S.M., Fritsche G., et al. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol 2007, 9:2126-2140.
33. Raffatellu M., George M.D., Akiyama Y., Hornsby M.J., Nuccio S.P., Paixao T.A., et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell host microbe 2009, 5:476-486.
34. Halaas O., Steigedal M., Haug M., Awuh J.A., Ryan L., Brech A., et al. Intracellular Mycobacterium avium intersect transferrin in the Rab11(+) recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway. J Infect Dis 2010, 201:783-792.
35. Saiga H., Nishimura J., Kuwata H., Okuyama M., Matsumoto S., Sato S., et al. Lipocalin 2-dependent inhibition of mycobacterial growth in alveolar epithelium. J Immunol 2008, 8521-8527.
36. Martineau A.R., Newton S.M., Wilkinson K.A., Kampmann B., Hall B.M., Nawroly N., et al. Neutrophil-mediated innate immune resistance to mycobacteria. J Clin Invest 2007, 117:1988-1994.
37. Jain S., De Petris L., Hoshi M., Akilesh S., Chatterjee R., Liapis H. Expression profiles of podocytes exposed to high glucose reveal new insights into early diabetic glomerulopathy. Lab Invest 2010.
38. Ding L., Hanawa H., Ota Y., Hasegawa G., Hao K., Asami F., et al. Lipocalin-2/neutrophil gelatinase-B associated lipocalin is strongly induced in hearts of rats with autoimmune myocarditis and in human myocarditis. Circ J 2010, 523-530.
39. Bu D.X., Hemdahl A.L., Gabrielsen A., Fuxe J., Zhu C., Eriksson P., et al. Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB. Am J Pathol 2006, 169:2245-2253.
40. Roudkenar M.H., Halabian R., Roushandeh A.M., Nourani M.R., Masroori N., Ebrahimi M., et al. Lipocalin 2 regulation by thermal stresses: protective role of Lcn2/NGAL against cold and heat stresses. Exp Cell Res 2009, 3140-3151.
41. Jessen B.A., Stevens G.J. Expression profiling during adipocyte differentiation of 3T3-L1 fibroblasts. Gene 2002, 95-100.
42. Tan B.K., Adya R., Shan X., Syed F., Lewandowski K.C., O'Hare J.P., et al. Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin. Diabetes Care 2009, 129-131.
43. Wang Y., Lam K.S., Kraegen E.W., Sweeney G., Zhang J., Tso A.W., et al. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007, 34-41.
44. Yan Q.W., Yang Q., Mody N., Graham T.E., Hsu C.H., Xu Z., et al. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 2007, 2533-2540.
45. Catalan V., Gomez-Ambrosi J., Rodriguez A., Ramirez B., Silva C., Rotellar F., et al. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans. J Mol Med 2009, 87:803-813.
46. Law I.K., Xu A., Lam K.S., Berger T., Mak T.W., Vanhoutte P.M., et al. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 2010, 872-882.
47. Guo H., Jin D., Zhang Y., Wright W., Bazuine M., Brockman D.A., et al. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 2010, 59:1376-1385.
48. Guttman-Yassky E., Lowes M.A., Fuentes-Duculan J., Zaba L.C., Cardinale I., Nograles K.E., et al. Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J Immunol 2008, 181:7420-7427.
49. Bando M., Hiroshima Y., Kataoka M., Shinohara Y., Herzberg M.C., Ross K.F., et al. Interleukin-1alpha regulates antimicrobial peptide expression in human keratinocytes. Immunol Cell Biol 2007, 532-537.
50. Eagan T.M., Damas J.K., Ueland T., Voll-Aanerud M., Mollnes T.E., Hardie J.A., et al. Neutrophil gelatinase-associated lipocalin: a biomarker in COPD. Chest 2010, 888-895.
51. Andre E., Stoeger T., Takenaka S., Bahnweg M., Ritter B., Karg E., et al. Inhalation of ultrafine carbon particles triggers biphasic pro-inflammatory response in the mouse lung. Eur Respir J 2006, 28:275-285.
52. Katano M., Okamoto K., Arito M., Kawakami Y., Kurokawa M.S., Suematsu N., et al. Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Res Ther 2009, 11:R3.
53. Draper D.W., Bethea H.N., He Y.-W. Toll-like receptor 2-dependent and -independent activation of macrophages by group B streptococci. Immunol Lett 2006, 102:202-214.
54. Schurr J.R., Young E., Byrne P., Steele C., Shellito J.E., Kolls J.K. Central role of toll-like receptor 4 signaling and host defense in experimental pneumonia caused by Gram-negative bacteria. Infect Immun 2005, 73:532-545.
55. Cowland J.B., Sorensen O.E., Sehested M., Borregaard N. Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 2003, 171:6630-6639.
56. Cowland J.B., Muta T., Borregaard N. IL-1beta-specific up-regulation of neutrophil gelatinase-associated lipocalin is controlled by IkappaB-zeta. J Immunol 2006, 5559-5566.
57. Matsuo S., Yamazaki S., Takeshige K., Muta T. Crucial roles of binding sites for NF-kappaB and C/EBPs in IkappaB-zeta-mediated transcriptional activation. Biochem J 2007, 605-615.
58. Shen F., Ruddy M.J., Plamondon P., Gaffen S.L. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol 2005, 77:388-399.
59. Shen F., Hu Z., Goswami J., Gaffen S.L. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 2006, 24138-24148.
60. Karlsen J.R., Borregaard N., Cowland J.B. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta. J Biol Chem 2010, 14088-14100.
61. Gombart A.F., Kwok S.H., Anderson K.L., Yamaguchi Y., Torbett B.E., Koeffler H.P. Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1. Blood 2003, 3265-3273.
62. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxy vitamin D3. FASEB J 2005, 19:1067-1077.
63. Ho A.W., Shen F., Conti H.R., Patel N., Childs E.E., Peterson A.C., et al. IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail. J Immunol 2010, 1063-1070.
64. Shen F., Li N., Gade P., Kalvakolanu D.V., Weibley T., Doble B., et al. IL-17 receptor signaling inhibits C/EBPbeta by sequential phosphorylation of the regulatory 2 domain. Sci Signal 2009, 2:ra8.
65. Tsukada J., Yoshida Y., Kominato Y., Auron P.E. The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 2011.
66. Nelson D.E., Ihekwaba A.E., Elliott M., Johnson J.R., Gibney C.A., Foreman B.E., et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 2004, 306:704-708.
67. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008.
68. Valdebenito M., Muller S.I., Hantke K. Special conditions allow binding of the siderophore salmochelin to siderocalin (NGAL-lipocalin). FEMS Microbiol Lett 2007, 277:182-187.
69. Bachman M.A., Oyler J.E., Burns S.H., Caza M., Lepine F., Dozois C.M., et al. Klebsiella pneumoniae Yersiniabactin predisposes to respiratory tract infection through evasion of lipocalin 2. Infect Immun 2011.
70. Lawlor M.S., Hsu J., Rick P.D., Miller V.L. Identification of Klebsiella pneumoniae virulence determinants using an intranasal infection model. Mol Microbiol 2005, 58:1054-1073.
71. Lawlor M.S., O'Connor C., Miller V.L. Yersiniabactin is a virulence factor for Klebsiella pneumoniae during pulmonary infection. Infect Immun 2007, 75:1463-1472.
72. Chu B.C., Garcia-Herrero A., Johanson T.H., Krewulak K.D., Lau C.K., Peacock R.S., et al. Siderophore uptake in bacteria and the battle for iron with the host; a bird's eye view. Biometals 2010, 23:601-611.
73. Devireddy LR, Hart DO, Goetz DH, Green MR. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell. Elsevier Inc.; 2010. p. 1006-17.
74. Panidis D., Tziomalos K., Koiou E., Kandaraki E.A., Tsourdi E., Delkos D., et al. Reprod Biol Endocrinol 2010, 8:151.
75. Lee YH, Lee SH, Jung ES, Kim JS, Shim CY, Ko YG, et al. Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1. Atherosclerosis: Elsevier Ireland Ltd.; 2010.
76. Hekerman P., Zeidler J., Korfmacher S., Bamberg-Lemper S., Knobelspies H., Zabeau L., et al. BMC Mol Biol 2007, 41.
77. Zhang J., Wu Y., Zhang Y., Leroith D., Bernlohr D.A., Chen X. The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 2008, 22:1416-1426.
78. Gupta R.A., Brockman J.A., Sarraf P., Willson T.M., DuBois R.N. Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells. J Biol Chem 2001, 29681-29687.
79. Tong Z., Wu X., Kehrer J.P. Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. Biochem J 2003, 372:203-210.
80. Ulivi V., Cancedda R., Cancedda F.D. 15-Deoxy-delta 12, 14-prostaglandin J(2) inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX-2 in resolution of inflammation. J Cell Physiol 2008, 217:433-441.
81. Jin D., Guo H., Bu S.Y., Zhang Y., Hannaford J., Mashek D.G., et al. Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-{gamma} activation and function in lipid homeostasis and energy expenditure. FASEB J 2010.
82. Owen H.C., Roberts S.J., Ahmed S.F., Farquharson C. Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes. Am J Physiol Endocrinol Metab 2008, E1023-E1034.
83. Fujino R.S., Tanaka K., Morimatsu M., Tamura K., Kogo H., Hara T. Spermatogonial cell-mediated activation of an IkappaBzeta-independent nuclear factor-kappaB pathway in Sertoli cells induces transcription of the lipocalin-2 gene. Mol Endocrinol 2006, 20:904-915.
84. Ryon J., Bendickson L., Nilsen-Hamilton M. High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J 2002, 271-277.
85. Barasch J., Pressler L., Connor J., Malik A. A ureteric bud cell line induces nephrogenesis in two steps by two distinct signals. Am J Physiol 1996, 271:F50-F61.
86. Yang J., Goetz D., Li J.Y., Wang W., Mori K., Setlik D., et al. An iron delivery pathway mediated by a lipocalin. Mol Cell 2002, 1045-1056.
87. Gwira J.A., Wei F., Ishibe S., Ueland J.M., Barasch J., Cantley L.G. Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 2005, 7875-7882.
88. Viau A., El Karoui K., Laouari D., Burtin M., Nguyen C., Mori K., et al. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans. J Clin Invest 2010, 4065-4076.
89. Cui L., Xu L.Y., Shen Z.Y., Tao Q., Gao S.Y., Lv Z., et al. NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma. Clin Cancer Res 2008, 7674-7681.
90. Fang W.K., Xu L.Y., Lu X.F., Liao L.D., Cai W.J., Shen Z.Y., et al. A novel alternative spliced variant of neutrophil gelatinase-associated lipocalin receptor in oesophageal carcinoma cells. Biochem J 2007, 403:297-303.
91. Kubben F.J., Sier C.F., Hawinkels L.J., Tschesche H., van Duijn W., Zuidwijk K., et al. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer 2007, 43:1869-1876.
92. Tong Z., Kunnumakkara A.B., Wang H., Matsuo Y., Diagaradjane P., Harikumar K.B., et al. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res 2008, 68:6100-6108.
93. Lee S., Park J.Y., Lee W.H., Kim H., Park H.C., Mori K., et al. Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J Neurosci 2009, 234-249.
94. Lee S., Lee J., Kim S., Park J.Y., Lee W.H., Mori K., et al. A dual role of lipocalin 2 in the apoptosis and deramification of activated microglia. J Immunol 2007, 179:3231-3241.
95. Zheng L.T., Lee S., Yin G.N., Mori K., Suk K. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells. J Neurochem 2009, 1238-1251.
96. Gagliardi M., Maynard S., Miyake T., Rodrigues N., Tjew S.L., Cabannes E., et al. Opposing roles of C/EBPbeta and AP-1 in the control of fibroblast proliferation and growth arrest-specific gene expression. J Biol Chem 2003, 1:43846-43854.
97. Lin H.H., Li W.W., Lee Y.C., Chu S.T. Apoptosis induced by uterine 24p3 protein in endometrial carcinoma cell line. Toxicology 2007, 203-215.
98. Miharada K., Hiroyama T., Sudo K., Nagasawa T., Nakamura Y. Lipocalin 2 functions as a negative regulator of red blood cell production in an autocrine fashion. FASEB J 2005, 19:1881-1883.
99. Devireddy L.R., Teodoro J.G., Richard F.A., Green M.R. Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 2001, 829-834.
100. Devireddy L.R., Gazin C., Zhu X., Green M.R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005, 123:1293-1305.
101. Sheng Z., Wang S.Z., Green M.R. Transcription and signalling pathways involved in BCR-ABL-mediated misregulation of 24p3 and 24p3R. EMBO J 2009, 866-876.
102. Leng X., Lin H., Ding T., Wang Y., Wu Y., Klumpp S., et al. Lipocalin 2 is required for BCR-ABL-induced tumorigenesis. Oncogene 2008, 6110-6119.
103. Iannetti A., Pacifico F., Acquaviva R., Lavorgna A., Crescenzi E., Vascotto C., et al. The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci USA 2008, 14058-14063.
104. Klausen P., Niemann C.U., Cowland J.B., Krabbe K., Borregaard N. On mouse and man: neutrophil gelatinase associated lipocalin is not involved in apoptosis or acute response. Eur J Haematol 2005, 332-340.
105. Costa D, Biticchi R, Negrini S, Tasso R, Cancedda R, Descalzi F, et al. Lipocalin-2 controls the expression of SDF-1 and the number of responsive cells in bone. Cytokine: Elsevier Ltd.; 2010. p. 47-52.
106. Chudzinski-Tavassi AM, Carrijo-Carvalho LC, Waismam K, Farsky SH, Ramos OH, Reis CV. A lipocalin sequence signature modulates cell survival. FEBS Lett. Netherlands: Federation of European Biochemical Societies. Published by Elsevier B.V; 2010. p. 2896-900.
107. Leng X., Ding T., Lin H., Wang Y., Hu L., Hu J., et al. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res 2009, 8579-8584.
108. Berger T., Cheung C.C., Elia A.J., Mak T.W. Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis. Proc Natl Acad Sci USA 2010, 2995-3000.
109. Hanai J., Mammoto T., Seth P., Mori K., Karumanchi S.A., Barasch J., et al. Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. J Biol Chem 2005, 280:13641-13647.
110. Hu L., Hittelman W., Lu T., Ji P., Arlinghaus R., Shmulevich I., et al. NGAL decreases E-cadherin-mediated cell-cell adhesion and increases cell motility and invasion through Rac1 in colon carcinoma cells. Lab Invest 2009, 531-548.
111. Yang J., Bielenberg D.R., Rodig S.J., Doiron R., Clifton M.C., Kung A.L., et al. Lipocalin 2 promotes breast cancer progression. Proc Natl Acad Sci USA 2009, 3913-3918.
112. Fougere M., Gaudineau B., Barbier J., Guaddachi F., Feugeas J.P., Auboeuf D., et al. NFAT3 transcription factor inhibits breast cancer cell motility by targeting the lipocalin 2 gene. Oncogene 2010, 2292-2301.
113. Nemoto Y., Izumi Y., Tezuka K., Tamatani T., Irimura T. Comparison of 16 human colon carcinoma cell lines for their expression of sialyl LeX antigens and their E-selectin-dependent adhesion. Clin Exp Metastasis 1998, 16:569-576.
114. Gupta R.A., Sarraf P., Mueller E., Brockman J.A., Prusakiewicz J.J., Eng C., et al. Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms. J Biol Chem 2003, 278:22669-22677.
115. Cai L., Rubin J., Han W., Venge P., Xu S. The origin of multiple molecular forms in urine of HNL/NGAL. Clin J Am Soc Nephrol 2010.
116. Hvidberg V., Jacobsen C., Strong R.K., Cowland J.B., Moestrup S.K., Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 2005, 773-777.
117. Drummond A, Ashton B, Buxton S, Cheung M, Cooper A, Duran C, et al. Geneious v5.3. 2010. Available from http://www.geneious.com.